-
Samsung Galaxy Buds Active Leak Reveals ANC, Ear-Hook Design and One UI 9.5 Integration
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
Making the Most of a Long Weekend Without Leaving Town
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
Paul Scribner on General Holdings Limited's Role as a Principal Investor in Complex, Cross-Border Opportunities
-
Best Gold IRA Rollover Companies 2026 Announced: How to Choose and Gold IRA Rollover Basics Explained in New Guide
-
Remergify and Ready Set Fund Grow Launch Municipal Opportunity Zone Framework to Modernize Core Public Utilities and Bridge the Divide Between Luxury Growth and Community Stability
-
CreditRiskMonitor Trade Contributors Use New Self-Serve Feature
-
Caldwell Expands Leadership Advisory With Launch of Caldwell Leadership Intelligence
-
neoseek Builds on a Decade of Engineering Expertise to Accelerate Global Expansion in Portable Charging
-
Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4
-
Route1 Announces Issuance of Shares for Compensation
-
Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System
-
After 20 Years of Modernizing Other Companies' Software, Polcode Turns the Lens on Itself
-
Celtic Bank Selects Infinant to Scale Its Embedded Finance Programs
-
BlackBerry and Hazard Management Cayman Islands Renew Critical Alerting System for Emergencies and Public Safety
-
Long Island Capital Alliance to Host Technology Capital Forum
-
Philadelphia Sexual Assault Lawyer David P. Thiruselvam Explains Who Can Be Named in a Civil Sexual Assault Claim
Joe Biden diagnosed with aggressive prostate cancer
Former US president Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones, and is reviewing treatment options, a statement from his office said Sunday.
On Friday the 82-year-old Democrat was diagnosed with the cancer after he experienced increasing urinary symptoms and was seen for a new finding of a prostate nodule, the statement said.
"While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians," it continued.
Cancer cells are commonly found in the prostates of men of Biden's age, though in most cases they grow slowly. Hormone therapy is a common treatment that can shrink tumors and slow cancer growth, but is not a cure.
According to the statement, Biden's cancer was found to have "a Gleason score of 9 (Grade Group 5)."
Prostate cancer that looks "very abnormal" is assigned the highest rating, Grade 5, according to the American Cancer Society. The Gleason Score often indicates the sum of the grades from the two areas in the prostate that make up most of the cancer, but can also be calculated other ways.
Biden left office in January this year as the oldest serving US president in history, and was dogged by questions over his health and age for much of his presidency.
For years he had faced questions, including from Democratic voters, over whether he was too old -- lacking in mental acuity or physical endurance -- for a job as trying as the presidency.
His response to doubters was a brisk: "Watch me."
But in July last year he was forced to drop his reelection bid after a disastrous debate against Republican Donald Trump in which fears about his decline and cognitive abilities came surging to the fore.
His vice president, Kamala Harris, eventually lost to Trump.
Biden maintains that he could have won the election, but questions have long swirled over the responses of staff and key Democrats to evident signs of his decline.
They have flared with the release, set for this Tuesday, of "Original Sin: President Biden's Decline, Its Cover-Up, and His Disastrous Choice to Run Again" by CNN journalist Jake Tapper and Alex Thompson of Axios.
Last week a newly published recording of Biden speaking hesitantly and struggling to remember key events and dates fueled renewed debate over his mental capabilities while still in office.
Biden's life has been marked by personal tragedy. In 1972 his wife and baby daughter were killed in a car crash, days after he had been elected as a US senator at the age of 29.
Biden underwent surgery twice in 1988 for brain aneurysms. In 2023 he had a skin lesion -- a basal cell carcinoma -- removed from his chest. He had previously had non-melanoma skin cancers removed.
Biden's son Beau Biden died of brain cancer in 2015.
T.Ward--AMWN